Every Form 4 that DUKE ROBOTICS CORP NEW (DUKRD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow DUKRD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DUKRD filings page.
DUKE Robotics Corp. director Antebi Eran received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share. The option was fully unheld before this award, so his post-transaction derivative holdings in this grant are 4,000 options. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. This is a compensation-related award, not an open-market trade.
Zakai Shlomo reported acquisition or exercise transactions in this Form 4 filing.
DUKE Robotics Corp. chief financial officer Zakai Shlomo received a grant of options to purchase 10,000 shares of common stock, exercisable at $7.88 per share. The option expires on March 10, 2032 and vests in three equal annual installments beginning on March 10, 2027.
DUKE Robotics Corp. director Golan Keren Gousman received an option grant for 4,000 shares of common stock at an exercise price of $7.88 per share, expiring on March 10, 2032. The option vests in three equal annual installments beginning on March 10, 2027.
DUKE Robotics Corp. reported that Chief Technology Officer Maor Vadim received a grant of options to purchase 4,000 shares of common stock at an exercise price of $7.88 per share. These options are a form of equity compensation rather than an open‑market trade.
The options expire on March 10, 2032 and vest in three equal annual installments beginning on March 10, 2027. After this award, Vadim holds options for 4,000 underlying shares directly, with no sales or exercises reported in this filing.
DUKE Robotics Corp. chief executive officer Balucka Yossef received a grant of options to purchase 16,000 shares of common stock at an exercise price of $7.88 per share. The options vest in three equal annual installments beginning on March 10, 2027 and expire on March 10, 2032. Following the grant, he holds 16,000 options directly.
DUKE Robotics Corp. director Nachtomy Erez received an option grant covering 16,000 shares of common stock at an exercise price of $7.88 per share. The option vests in three equal annual installments beginning on March 10, 2027, and expires on March 10, 2032. Following this grant, Erez holds options on 16,000 shares directly.